The Omunis products are intended for healthcare workers and research teams within companies, associations, NGOs, hospitals, public and private laboratories, foundations, etc.
The Omunis’ R&D department is available to third parties in the form of service or research collaboration to customize development and/or validation of open molecular biology tests at reduced costs for specific applications in the field of infectious diseases.
Feel free to contact us for more information and to be kept informed of our progress and developments, the commercial availability of our kits and reagents, or to follow the regulatory status changes of our products.